Monday, October 30, 2006

Health Plans Try New Tactics to Spur Generic Drug Utilization

As blockbuster medications lose patent protection this year, some insurers are employing a variety of strategies to boost generic drug uptake — such as waiving copayments for specific drug categories or moving medications that are about to get generic equivalents onto preferred formulary lists with lower copays. But others have shied away from drug-specific tactics and are instead focused on lower copays to encourage generic use.

More than a dozen of the nation's best-selling prescription drugs have lost or are expected to lose patent protection this year through 2010.

Article can be view in its entirety at Managed Care.

0 Comments:

Post a Comment

<< Home